Global Sleep Disorder Treatment Drugs Market

Sleep Disorder Treatment Drugs Comprehensive Study by Type (Prescription-based Drugs, OTC Drugs, Herbal Drugs), Application (Hospitals, Clinics, Research Centers, Others), Sleep disorder (Insomnia, Sleep Apnea, Restless Legs Syndrome, Narcolepsy, Sleep Walking), Devices (Positive Airway Pressure (PAP) Devices, Facial Interfaces, Oral Appliances, Adaptive Servo-Ventilators (ASVs), Others) Players and Region - Global Market Outlook to 2030

Sleep Disorder Treatment Drugs Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 5.5%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Sleep Disorder Treatment Drugs Market Scope
Sleep disorder is also known as sominpathy or insomnia is a medical disorder in which the patient experience difficulty in sleep maintenance or sleep initiation. Symptoms for this disorder include mental, physical, social, and emotional functions. Lack of sleep has a negative impact on the health of a person. The prevalence of sleep disorders has been significantly increased which is a primary factor fostering the market growth. Reportedly, in the United States, over 75% of people aged between 20 and 59 years have sleeping difficulties frequently.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
Key Companies ProfiledPfizer (United States), Sanofi (France), Merck Sharp & Dohme Corporation (United States), GlaxoSmithKline (United Kingdom), Koninklijke Philips N.V. (Netherlands), Takeda Pharmaceutical Company (Japan), Leva Pharmaceutical Industries (Pakistan) and Cardinal Health, Inc. (United States)
CAGR5.5%


The Global Sleep Disorder Treatment Drugs market is fragmented with several market players who are involved in many strategic collaborations and product launch. For instance, November 2018, DNDi and Sanofi will donate the medicine in support of international efforts to eliminate the disease. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Sleep Disorder Treatment Drugs market throughout the predicted period.

Pfizer (United States), Sanofi (France), Merck Sharp & Dohme Corporation (United States), GlaxoSmithKline (United Kingdom), Koninklijke Philips N.V. (Netherlands), Takeda Pharmaceutical Company (Japan), Leva Pharmaceutical Industries (Pakistan) and Cardinal Health, Inc. (United States) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Becton Dickson and Company (United States) and Natus Medicalorporated (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Sleep Disorder Treatment Drugs market by Type , by Application (Hospitals, Clinics, Research Centers and Others) and Region with country level break-up.

On the basis of geography, the market of Sleep Disorder Treatment Drugs has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2023.

Market Leaders and their expansionary development strategies
In March 2019, Jazz Pharmaceuticals plc announced that the Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea (OSA). and January 2019, New Drug Application for Insomnia Disorder Treatment i.e.Lemborexant Submitted to FDA. Lemborexant, an investigational agent for sleep-wake regulation, seeking approval for the treatment of insomnia, a sleep-wake disorder. This application was based on the results of two pivotal Phase 3 clinical studies in patients with insomnia.
In March 2018, Drive DeVilbiss Healthcare introduced the next generation Trotter Mobility Chair. The product offers parents and caregivers a lightweight, foldable alternative to heavier wheelchair-style mobility bases. The new generation Trotter features a padded seat and back upholstery at the same low price as the original version. New accessories include angle adjustable footplates, anti-tippers, contoured headwings, headrest extension, canopy, under-seat carrier and Poziform ankle positioners.
November 2018, the European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness. This approval is a result of clinical trials led by the non-profit research and development organization DNDi and an application submitted by Sanofi.

Influencing Trend:
Introduction of Home Sleep Test Kits and Wearable Monitors, Advent of Continuous Positive Airway Pressure (CPAP) Therapy and Affordable Reimbursement Scenario for Drugs prescribed in Insomnia Treatment

Market Growth Drivers:
Increasing Incidence of Depression & Medical Disorder, Rising Geriatric Population and Associated Sleep Disorder and High Usage of Sleep Apnea Devices and Growing Healthcare Facilities

Challenges:
Patent Expiration of Sleep Disorder Treatment Drugs

Restraints:
Side Effects Associated with the Drug used to Treat Sleep Disorder

Opportunities:
Rising Investment on Research and Development of Drugs for the Sleep disorder

Key Target Audience
Sleep Disorder Treatment Drugs Manufacturer, Industry Associations, Potential Investors, Supplier, Traders & Distributors, Government and Regulatory Bodies and Others

Report Objectives / Segmentation Covered

By Type
  • Prescription-based Drugs
  • OTC Drugs
  • Herbal Drugs
By Application
  • Hospitals
  • Clinics
  • Research Centers
  • Others
By Sleep disorder
  • Insomnia
  • Sleep Apnea
  • Restless Legs Syndrome
  • Narcolepsy
  • Sleep Walking

By Devices
  • Positive Airway Pressure (PAP) Devices
  • Facial Interfaces
  • Oral Appliances
  • Adaptive Servo-Ventilators (ASVs)
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Incidence of Depression & Medical Disorder
      • 3.2.2. Rising Geriatric Population and Associated Sleep Disorder
      • 3.2.3. High Usage of Sleep Apnea Devices and Growing Healthcare Facilities
    • 3.3. Market Challenges
      • 3.3.1. Patent Expiration of Sleep Disorder Treatment Drugs
    • 3.4. Market Trends
      • 3.4.1. Introduction of Home Sleep Test Kits and Wearable Monitors
      • 3.4.2. Advent of Continuous Positive Airway Pressure (CPAP) Therapy
      • 3.4.3. Affordable Reimbursement Scenario for Drugs prescribed in Insomnia Treatment
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Sleep Disorder Treatment Drugs, by Type, Application, Sleep disorder, Devices and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Sleep Disorder Treatment Drugs (Value)
      • 5.2.1. Global Sleep Disorder Treatment Drugs by: Type (Value)
        • 5.2.1.1. Prescription-based Drugs
        • 5.2.1.2. OTC Drugs
        • 5.2.1.3. Herbal Drugs
      • 5.2.2. Global Sleep Disorder Treatment Drugs by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Research Centers
        • 5.2.2.4. Others
      • 5.2.3. Global Sleep Disorder Treatment Drugs by: Sleep disorder (Value)
        • 5.2.3.1. Insomnia
        • 5.2.3.2. Sleep Apnea
        • 5.2.3.3. Restless Legs Syndrome
        • 5.2.3.4. Narcolepsy
        • 5.2.3.5. Sleep Walking
      • 5.2.4. Global Sleep Disorder Treatment Drugs by: Devices (Value)
        • 5.2.4.1. Positive Airway Pressure (PAP) Devices
        • 5.2.4.2. Facial Interfaces
        • 5.2.4.3. Oral Appliances
        • 5.2.4.4. Adaptive Servo-Ventilators (ASVs)
        • 5.2.4.5. Others
      • 5.2.5. Global Sleep Disorder Treatment Drugs Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Sleep Disorder Treatment Drugs (Volume)
      • 5.3.1. Global Sleep Disorder Treatment Drugs by: Type (Volume)
        • 5.3.1.1. Prescription-based Drugs
        • 5.3.1.2. OTC Drugs
        • 5.3.1.3. Herbal Drugs
      • 5.3.2. Global Sleep Disorder Treatment Drugs by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Research Centers
        • 5.3.2.4. Others
      • 5.3.3. Global Sleep Disorder Treatment Drugs by: Sleep disorder (Volume)
        • 5.3.3.1. Insomnia
        • 5.3.3.2. Sleep Apnea
        • 5.3.3.3. Restless Legs Syndrome
        • 5.3.3.4. Narcolepsy
        • 5.3.3.5. Sleep Walking
      • 5.3.4. Global Sleep Disorder Treatment Drugs by: Devices (Volume)
        • 5.3.4.1. Positive Airway Pressure (PAP) Devices
        • 5.3.4.2. Facial Interfaces
        • 5.3.4.3. Oral Appliances
        • 5.3.4.4. Adaptive Servo-Ventilators (ASVs)
        • 5.3.4.5. Others
      • 5.3.5. Global Sleep Disorder Treatment Drugs Region
        • 5.3.5.1. South America
          • 5.3.5.1.1. Brazil
          • 5.3.5.1.2. Argentina
          • 5.3.5.1.3. Rest of South America
        • 5.3.5.2. Asia Pacific
          • 5.3.5.2.1. China
          • 5.3.5.2.2. Japan
          • 5.3.5.2.3. India
          • 5.3.5.2.4. South Korea
          • 5.3.5.2.5. Taiwan
          • 5.3.5.2.6. Australia
          • 5.3.5.2.7. Rest of Asia-Pacific
        • 5.3.5.3. Europe
          • 5.3.5.3.1. Germany
          • 5.3.5.3.2. France
          • 5.3.5.3.3. Italy
          • 5.3.5.3.4. United Kingdom
          • 5.3.5.3.5. Netherlands
          • 5.3.5.3.6. Rest of Europe
        • 5.3.5.4. MEA
          • 5.3.5.4.1. Middle East
          • 5.3.5.4.2. Africa
        • 5.3.5.5. North America
          • 5.3.5.5.1. United States
          • 5.3.5.5.2. Canada
          • 5.3.5.5.3. Mexico
    • 5.4. Global Sleep Disorder Treatment Drugs (Price)
      • 5.4.1. Global Sleep Disorder Treatment Drugs by: Type (Price)
  • 6. Sleep Disorder Treatment Drugs: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sanofi (France)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck Sharp & Dohme Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GlaxoSmithKline (United Kingdom)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Koninklijke Philips N.V. (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Takeda Pharmaceutical Company (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Leva Pharmaceutical Industries (Pakistan)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Cardinal Health, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Sleep Disorder Treatment Drugs Sale, by Type, Application, Sleep disorder, Devices and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Sleep Disorder Treatment Drugs (Value)
      • 7.2.1. Global Sleep Disorder Treatment Drugs by: Type (Value)
        • 7.2.1.1. Prescription-based Drugs
        • 7.2.1.2. OTC Drugs
        • 7.2.1.3. Herbal Drugs
      • 7.2.2. Global Sleep Disorder Treatment Drugs by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Research Centers
        • 7.2.2.4. Others
      • 7.2.3. Global Sleep Disorder Treatment Drugs by: Sleep disorder (Value)
        • 7.2.3.1. Insomnia
        • 7.2.3.2. Sleep Apnea
        • 7.2.3.3. Restless Legs Syndrome
        • 7.2.3.4. Narcolepsy
        • 7.2.3.5. Sleep Walking
      • 7.2.4. Global Sleep Disorder Treatment Drugs by: Devices (Value)
        • 7.2.4.1. Positive Airway Pressure (PAP) Devices
        • 7.2.4.2. Facial Interfaces
        • 7.2.4.3. Oral Appliances
        • 7.2.4.4. Adaptive Servo-Ventilators (ASVs)
        • 7.2.4.5. Others
      • 7.2.5. Global Sleep Disorder Treatment Drugs Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Sleep Disorder Treatment Drugs (Volume)
      • 7.3.1. Global Sleep Disorder Treatment Drugs by: Type (Volume)
        • 7.3.1.1. Prescription-based Drugs
        • 7.3.1.2. OTC Drugs
        • 7.3.1.3. Herbal Drugs
      • 7.3.2. Global Sleep Disorder Treatment Drugs by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Research Centers
        • 7.3.2.4. Others
      • 7.3.3. Global Sleep Disorder Treatment Drugs by: Sleep disorder (Volume)
        • 7.3.3.1. Insomnia
        • 7.3.3.2. Sleep Apnea
        • 7.3.3.3. Restless Legs Syndrome
        • 7.3.3.4. Narcolepsy
        • 7.3.3.5. Sleep Walking
      • 7.3.4. Global Sleep Disorder Treatment Drugs by: Devices (Volume)
        • 7.3.4.1. Positive Airway Pressure (PAP) Devices
        • 7.3.4.2. Facial Interfaces
        • 7.3.4.3. Oral Appliances
        • 7.3.4.4. Adaptive Servo-Ventilators (ASVs)
        • 7.3.4.5. Others
      • 7.3.5. Global Sleep Disorder Treatment Drugs Region
        • 7.3.5.1. South America
          • 7.3.5.1.1. Brazil
          • 7.3.5.1.2. Argentina
          • 7.3.5.1.3. Rest of South America
        • 7.3.5.2. Asia Pacific
          • 7.3.5.2.1. China
          • 7.3.5.2.2. Japan
          • 7.3.5.2.3. India
          • 7.3.5.2.4. South Korea
          • 7.3.5.2.5. Taiwan
          • 7.3.5.2.6. Australia
          • 7.3.5.2.7. Rest of Asia-Pacific
        • 7.3.5.3. Europe
          • 7.3.5.3.1. Germany
          • 7.3.5.3.2. France
          • 7.3.5.3.3. Italy
          • 7.3.5.3.4. United Kingdom
          • 7.3.5.3.5. Netherlands
          • 7.3.5.3.6. Rest of Europe
        • 7.3.5.4. MEA
          • 7.3.5.4.1. Middle East
          • 7.3.5.4.2. Africa
        • 7.3.5.5. North America
          • 7.3.5.5.1. United States
          • 7.3.5.5.2. Canada
          • 7.3.5.5.3. Mexico
    • 7.4. Global Sleep Disorder Treatment Drugs (Price)
      • 7.4.1. Global Sleep Disorder Treatment Drugs by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Sleep Disorder Treatment Drugs: by Type(USD Million)
  • Table 2. Sleep Disorder Treatment Drugs Prescription-based Drugs , by Region USD Million (2018-2023)
  • Table 3. Sleep Disorder Treatment Drugs OTC Drugs , by Region USD Million (2018-2023)
  • Table 4. Sleep Disorder Treatment Drugs Herbal Drugs , by Region USD Million (2018-2023)
  • Table 5. Sleep Disorder Treatment Drugs: by Application(USD Million)
  • Table 6. Sleep Disorder Treatment Drugs Hospitals , by Region USD Million (2018-2023)
  • Table 7. Sleep Disorder Treatment Drugs Clinics , by Region USD Million (2018-2023)
  • Table 8. Sleep Disorder Treatment Drugs Research Centers , by Region USD Million (2018-2023)
  • Table 9. Sleep Disorder Treatment Drugs Others , by Region USD Million (2018-2023)
  • Table 10. Sleep Disorder Treatment Drugs: by Sleep disorder(USD Million)
  • Table 11. Sleep Disorder Treatment Drugs Insomnia , by Region USD Million (2018-2023)
  • Table 12. Sleep Disorder Treatment Drugs Sleep Apnea , by Region USD Million (2018-2023)
  • Table 13. Sleep Disorder Treatment Drugs Restless Legs Syndrome , by Region USD Million (2018-2023)
  • Table 14. Sleep Disorder Treatment Drugs Narcolepsy , by Region USD Million (2018-2023)
  • Table 15. Sleep Disorder Treatment Drugs Sleep Walking , by Region USD Million (2018-2023)
  • Table 16. Sleep Disorder Treatment Drugs: by Devices(USD Million)
  • Table 17. Sleep Disorder Treatment Drugs Positive Airway Pressure (PAP) Devices , by Region USD Million (2018-2023)
  • Table 18. Sleep Disorder Treatment Drugs Facial Interfaces , by Region USD Million (2018-2023)
  • Table 19. Sleep Disorder Treatment Drugs Oral Appliances , by Region USD Million (2018-2023)
  • Table 20. Sleep Disorder Treatment Drugs Adaptive Servo-Ventilators (ASVs) , by Region USD Million (2018-2023)
  • Table 21. Sleep Disorder Treatment Drugs Others , by Region USD Million (2018-2023)
  • Table 22. South America Sleep Disorder Treatment Drugs, by Country USD Million (2018-2023)
  • Table 23. South America Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 24. South America Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 25. South America Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 26. South America Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 27. Brazil Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 28. Brazil Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 29. Brazil Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 30. Brazil Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 31. Argentina Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 32. Argentina Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 33. Argentina Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 34. Argentina Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 35. Rest of South America Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 36. Rest of South America Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 37. Rest of South America Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 38. Rest of South America Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 39. Asia Pacific Sleep Disorder Treatment Drugs, by Country USD Million (2018-2023)
  • Table 40. Asia Pacific Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 41. Asia Pacific Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 42. Asia Pacific Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 43. Asia Pacific Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 44. China Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 45. China Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 46. China Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 47. China Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 48. Japan Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 49. Japan Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 50. Japan Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 51. Japan Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 52. India Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 53. India Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 54. India Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 55. India Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 56. South Korea Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 57. South Korea Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 58. South Korea Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 59. South Korea Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 60. Taiwan Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 61. Taiwan Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 62. Taiwan Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 63. Taiwan Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 64. Australia Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 65. Australia Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 66. Australia Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 67. Australia Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 70. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 72. Europe Sleep Disorder Treatment Drugs, by Country USD Million (2018-2023)
  • Table 73. Europe Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 74. Europe Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 75. Europe Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 76. Europe Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 77. Germany Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 78. Germany Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 79. Germany Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 80. Germany Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 81. France Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 82. France Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 83. France Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 84. France Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 85. Italy Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 86. Italy Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 87. Italy Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 88. Italy Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 89. United Kingdom Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 90. United Kingdom Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 91. United Kingdom Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 92. United Kingdom Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 93. Netherlands Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 94. Netherlands Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 95. Netherlands Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 96. Netherlands Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 97. Rest of Europe Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 98. Rest of Europe Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 99. Rest of Europe Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 100. Rest of Europe Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 101. MEA Sleep Disorder Treatment Drugs, by Country USD Million (2018-2023)
  • Table 102. MEA Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 103. MEA Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 104. MEA Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 105. MEA Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 106. Middle East Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 107. Middle East Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 108. Middle East Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 109. Middle East Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 110. Africa Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 111. Africa Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 112. Africa Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 113. Africa Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 114. North America Sleep Disorder Treatment Drugs, by Country USD Million (2018-2023)
  • Table 115. North America Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 116. North America Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 117. North America Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 118. North America Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 119. United States Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 120. United States Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 121. United States Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 122. United States Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 123. Canada Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 124. Canada Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 125. Canada Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 126. Canada Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 127. Mexico Sleep Disorder Treatment Drugs, by Type USD Million (2018-2023)
  • Table 128. Mexico Sleep Disorder Treatment Drugs, by Application USD Million (2018-2023)
  • Table 129. Mexico Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2018-2023)
  • Table 130. Mexico Sleep Disorder Treatment Drugs, by Devices USD Million (2018-2023)
  • Table 131. Sleep Disorder Treatment Drugs Sales: by Type(K Units)
  • Table 132. Sleep Disorder Treatment Drugs Sales Prescription-based Drugs , by Region K Units (2018-2023)
  • Table 133. Sleep Disorder Treatment Drugs Sales OTC Drugs , by Region K Units (2018-2023)
  • Table 134. Sleep Disorder Treatment Drugs Sales Herbal Drugs , by Region K Units (2018-2023)
  • Table 135. Sleep Disorder Treatment Drugs Sales: by Application(K Units)
  • Table 136. Sleep Disorder Treatment Drugs Sales Hospitals , by Region K Units (2018-2023)
  • Table 137. Sleep Disorder Treatment Drugs Sales Clinics , by Region K Units (2018-2023)
  • Table 138. Sleep Disorder Treatment Drugs Sales Research Centers , by Region K Units (2018-2023)
  • Table 139. Sleep Disorder Treatment Drugs Sales Others , by Region K Units (2018-2023)
  • Table 140. Sleep Disorder Treatment Drugs Sales: by Sleep disorder(K Units)
  • Table 141. Sleep Disorder Treatment Drugs Sales Insomnia , by Region K Units (2018-2023)
  • Table 142. Sleep Disorder Treatment Drugs Sales Sleep Apnea , by Region K Units (2018-2023)
  • Table 143. Sleep Disorder Treatment Drugs Sales Restless Legs Syndrome , by Region K Units (2018-2023)
  • Table 144. Sleep Disorder Treatment Drugs Sales Narcolepsy , by Region K Units (2018-2023)
  • Table 145. Sleep Disorder Treatment Drugs Sales Sleep Walking , by Region K Units (2018-2023)
  • Table 146. Sleep Disorder Treatment Drugs Sales: by Devices(K Units)
  • Table 147. Sleep Disorder Treatment Drugs Sales Positive Airway Pressure (PAP) Devices , by Region K Units (2018-2023)
  • Table 148. Sleep Disorder Treatment Drugs Sales Facial Interfaces , by Region K Units (2018-2023)
  • Table 149. Sleep Disorder Treatment Drugs Sales Oral Appliances , by Region K Units (2018-2023)
  • Table 150. Sleep Disorder Treatment Drugs Sales Adaptive Servo-Ventilators (ASVs) , by Region K Units (2018-2023)
  • Table 151. Sleep Disorder Treatment Drugs Sales Others , by Region K Units (2018-2023)
  • Table 152. South America Sleep Disorder Treatment Drugs Sales, by Country K Units (2018-2023)
  • Table 153. South America Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 154. South America Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 155. South America Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 156. South America Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 157. Brazil Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 158. Brazil Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 159. Brazil Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 160. Brazil Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 161. Argentina Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 162. Argentina Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 163. Argentina Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 164. Argentina Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 165. Rest of South America Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 166. Rest of South America Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 167. Rest of South America Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 168. Rest of South America Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 169. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Country K Units (2018-2023)
  • Table 170. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 171. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 172. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 173. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 174. China Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 175. China Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 176. China Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 177. China Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 178. Japan Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 179. Japan Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 180. Japan Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 181. Japan Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 182. India Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 183. India Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 184. India Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 185. India Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 186. South Korea Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 187. South Korea Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 188. South Korea Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 189. South Korea Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 190. Taiwan Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 191. Taiwan Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 192. Taiwan Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 193. Taiwan Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 194. Australia Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 195. Australia Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 196. Australia Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 197. Australia Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 198. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 199. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 200. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 201. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 202. Europe Sleep Disorder Treatment Drugs Sales, by Country K Units (2018-2023)
  • Table 203. Europe Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 204. Europe Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 205. Europe Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 206. Europe Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 207. Germany Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 208. Germany Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 209. Germany Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 210. Germany Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 211. France Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 212. France Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 213. France Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 214. France Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 215. Italy Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 216. Italy Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 217. Italy Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 218. Italy Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 219. United Kingdom Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 220. United Kingdom Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 221. United Kingdom Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 222. United Kingdom Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 223. Netherlands Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 224. Netherlands Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 225. Netherlands Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 226. Netherlands Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 227. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 228. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 229. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 230. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 231. MEA Sleep Disorder Treatment Drugs Sales, by Country K Units (2018-2023)
  • Table 232. MEA Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 233. MEA Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 234. MEA Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 235. MEA Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 236. Middle East Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 237. Middle East Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 238. Middle East Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 239. Middle East Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 240. Africa Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 241. Africa Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 242. Africa Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 243. Africa Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 244. North America Sleep Disorder Treatment Drugs Sales, by Country K Units (2018-2023)
  • Table 245. North America Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 246. North America Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 247. North America Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 248. North America Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 249. United States Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 250. United States Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 251. United States Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 252. United States Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 253. Canada Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 254. Canada Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 255. Canada Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 256. Canada Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 257. Mexico Sleep Disorder Treatment Drugs Sales, by Type K Units (2018-2023)
  • Table 258. Mexico Sleep Disorder Treatment Drugs Sales, by Application K Units (2018-2023)
  • Table 259. Mexico Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2018-2023)
  • Table 260. Mexico Sleep Disorder Treatment Drugs Sales, by Devices K Units (2018-2023)
  • Table 261. Sleep Disorder Treatment Drugs: by Type(USD/Units)
  • Table 262. Company Basic Information, Sales Area and Its Competitors
  • Table 263. Company Basic Information, Sales Area and Its Competitors
  • Table 264. Company Basic Information, Sales Area and Its Competitors
  • Table 265. Company Basic Information, Sales Area and Its Competitors
  • Table 266. Company Basic Information, Sales Area and Its Competitors
  • Table 267. Company Basic Information, Sales Area and Its Competitors
  • Table 268. Company Basic Information, Sales Area and Its Competitors
  • Table 269. Company Basic Information, Sales Area and Its Competitors
  • Table 270. Sleep Disorder Treatment Drugs: by Type(USD Million)
  • Table 271. Sleep Disorder Treatment Drugs Prescription-based Drugs , by Region USD Million (2025-2030)
  • Table 272. Sleep Disorder Treatment Drugs OTC Drugs , by Region USD Million (2025-2030)
  • Table 273. Sleep Disorder Treatment Drugs Herbal Drugs , by Region USD Million (2025-2030)
  • Table 274. Sleep Disorder Treatment Drugs: by Application(USD Million)
  • Table 275. Sleep Disorder Treatment Drugs Hospitals , by Region USD Million (2025-2030)
  • Table 276. Sleep Disorder Treatment Drugs Clinics , by Region USD Million (2025-2030)
  • Table 277. Sleep Disorder Treatment Drugs Research Centers , by Region USD Million (2025-2030)
  • Table 278. Sleep Disorder Treatment Drugs Others , by Region USD Million (2025-2030)
  • Table 279. Sleep Disorder Treatment Drugs: by Sleep disorder(USD Million)
  • Table 280. Sleep Disorder Treatment Drugs Insomnia , by Region USD Million (2025-2030)
  • Table 281. Sleep Disorder Treatment Drugs Sleep Apnea , by Region USD Million (2025-2030)
  • Table 282. Sleep Disorder Treatment Drugs Restless Legs Syndrome , by Region USD Million (2025-2030)
  • Table 283. Sleep Disorder Treatment Drugs Narcolepsy , by Region USD Million (2025-2030)
  • Table 284. Sleep Disorder Treatment Drugs Sleep Walking , by Region USD Million (2025-2030)
  • Table 285. Sleep Disorder Treatment Drugs: by Devices(USD Million)
  • Table 286. Sleep Disorder Treatment Drugs Positive Airway Pressure (PAP) Devices , by Region USD Million (2025-2030)
  • Table 287. Sleep Disorder Treatment Drugs Facial Interfaces , by Region USD Million (2025-2030)
  • Table 288. Sleep Disorder Treatment Drugs Oral Appliances , by Region USD Million (2025-2030)
  • Table 289. Sleep Disorder Treatment Drugs Adaptive Servo-Ventilators (ASVs) , by Region USD Million (2025-2030)
  • Table 290. Sleep Disorder Treatment Drugs Others , by Region USD Million (2025-2030)
  • Table 291. South America Sleep Disorder Treatment Drugs, by Country USD Million (2025-2030)
  • Table 292. South America Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 293. South America Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 294. South America Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 295. South America Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 296. Brazil Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 297. Brazil Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 298. Brazil Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 299. Brazil Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 300. Argentina Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 301. Argentina Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 302. Argentina Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 303. Argentina Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 304. Rest of South America Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 305. Rest of South America Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 306. Rest of South America Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 307. Rest of South America Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 308. Asia Pacific Sleep Disorder Treatment Drugs, by Country USD Million (2025-2030)
  • Table 309. Asia Pacific Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 310. Asia Pacific Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 311. Asia Pacific Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 312. Asia Pacific Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 313. China Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 314. China Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 315. China Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 316. China Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 317. Japan Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 318. Japan Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 319. Japan Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 320. Japan Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 321. India Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 322. India Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 323. India Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 324. India Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 325. South Korea Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 326. South Korea Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 327. South Korea Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 328. South Korea Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 329. Taiwan Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 330. Taiwan Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 331. Taiwan Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 332. Taiwan Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 333. Australia Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 334. Australia Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 335. Australia Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 336. Australia Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 337. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 338. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 339. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 340. Rest of Asia-Pacific Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 341. Europe Sleep Disorder Treatment Drugs, by Country USD Million (2025-2030)
  • Table 342. Europe Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 343. Europe Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 344. Europe Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 345. Europe Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 346. Germany Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 347. Germany Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 348. Germany Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 349. Germany Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 350. France Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 351. France Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 352. France Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 353. France Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 354. Italy Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 355. Italy Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 356. Italy Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 357. Italy Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 358. United Kingdom Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 359. United Kingdom Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 360. United Kingdom Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 361. United Kingdom Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 362. Netherlands Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 363. Netherlands Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 364. Netherlands Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 365. Netherlands Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 366. Rest of Europe Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 367. Rest of Europe Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 368. Rest of Europe Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 369. Rest of Europe Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 370. MEA Sleep Disorder Treatment Drugs, by Country USD Million (2025-2030)
  • Table 371. MEA Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 372. MEA Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 373. MEA Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 374. MEA Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 375. Middle East Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 376. Middle East Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 377. Middle East Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 378. Middle East Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 379. Africa Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 380. Africa Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 381. Africa Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 382. Africa Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 383. North America Sleep Disorder Treatment Drugs, by Country USD Million (2025-2030)
  • Table 384. North America Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 385. North America Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 386. North America Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 387. North America Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 388. United States Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 389. United States Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 390. United States Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 391. United States Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 392. Canada Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 393. Canada Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 394. Canada Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 395. Canada Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 396. Mexico Sleep Disorder Treatment Drugs, by Type USD Million (2025-2030)
  • Table 397. Mexico Sleep Disorder Treatment Drugs, by Application USD Million (2025-2030)
  • Table 398. Mexico Sleep Disorder Treatment Drugs, by Sleep disorder USD Million (2025-2030)
  • Table 399. Mexico Sleep Disorder Treatment Drugs, by Devices USD Million (2025-2030)
  • Table 400. Sleep Disorder Treatment Drugs Sales: by Type(K Units)
  • Table 401. Sleep Disorder Treatment Drugs Sales Prescription-based Drugs , by Region K Units (2025-2030)
  • Table 402. Sleep Disorder Treatment Drugs Sales OTC Drugs , by Region K Units (2025-2030)
  • Table 403. Sleep Disorder Treatment Drugs Sales Herbal Drugs , by Region K Units (2025-2030)
  • Table 404. Sleep Disorder Treatment Drugs Sales: by Application(K Units)
  • Table 405. Sleep Disorder Treatment Drugs Sales Hospitals , by Region K Units (2025-2030)
  • Table 406. Sleep Disorder Treatment Drugs Sales Clinics , by Region K Units (2025-2030)
  • Table 407. Sleep Disorder Treatment Drugs Sales Research Centers , by Region K Units (2025-2030)
  • Table 408. Sleep Disorder Treatment Drugs Sales Others , by Region K Units (2025-2030)
  • Table 409. Sleep Disorder Treatment Drugs Sales: by Sleep disorder(K Units)
  • Table 410. Sleep Disorder Treatment Drugs Sales Insomnia , by Region K Units (2025-2030)
  • Table 411. Sleep Disorder Treatment Drugs Sales Sleep Apnea , by Region K Units (2025-2030)
  • Table 412. Sleep Disorder Treatment Drugs Sales Restless Legs Syndrome , by Region K Units (2025-2030)
  • Table 413. Sleep Disorder Treatment Drugs Sales Narcolepsy , by Region K Units (2025-2030)
  • Table 414. Sleep Disorder Treatment Drugs Sales Sleep Walking , by Region K Units (2025-2030)
  • Table 415. Sleep Disorder Treatment Drugs Sales: by Devices(K Units)
  • Table 416. Sleep Disorder Treatment Drugs Sales Positive Airway Pressure (PAP) Devices , by Region K Units (2025-2030)
  • Table 417. Sleep Disorder Treatment Drugs Sales Facial Interfaces , by Region K Units (2025-2030)
  • Table 418. Sleep Disorder Treatment Drugs Sales Oral Appliances , by Region K Units (2025-2030)
  • Table 419. Sleep Disorder Treatment Drugs Sales Adaptive Servo-Ventilators (ASVs) , by Region K Units (2025-2030)
  • Table 420. Sleep Disorder Treatment Drugs Sales Others , by Region K Units (2025-2030)
  • Table 421. South America Sleep Disorder Treatment Drugs Sales, by Country K Units (2025-2030)
  • Table 422. South America Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 423. South America Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 424. South America Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 425. South America Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 426. Brazil Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 427. Brazil Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 428. Brazil Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 429. Brazil Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 430. Argentina Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 431. Argentina Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 432. Argentina Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 433. Argentina Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 434. Rest of South America Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 435. Rest of South America Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 436. Rest of South America Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 437. Rest of South America Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 438. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Country K Units (2025-2030)
  • Table 439. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 440. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 441. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 442. Asia Pacific Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 443. China Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 444. China Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 445. China Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 446. China Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 447. Japan Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 448. Japan Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 449. Japan Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 450. Japan Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 451. India Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 452. India Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 453. India Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 454. India Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 455. South Korea Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 456. South Korea Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 457. South Korea Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 458. South Korea Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 459. Taiwan Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 460. Taiwan Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 461. Taiwan Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 462. Taiwan Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 463. Australia Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 464. Australia Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 465. Australia Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 466. Australia Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 467. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 468. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 469. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 470. Rest of Asia-Pacific Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 471. Europe Sleep Disorder Treatment Drugs Sales, by Country K Units (2025-2030)
  • Table 472. Europe Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 473. Europe Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 474. Europe Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 475. Europe Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 476. Germany Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 477. Germany Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 478. Germany Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 479. Germany Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 480. France Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 481. France Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 482. France Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 483. France Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 484. Italy Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 485. Italy Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 486. Italy Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 487. Italy Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 488. United Kingdom Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 489. United Kingdom Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 490. United Kingdom Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 491. United Kingdom Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 492. Netherlands Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 493. Netherlands Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 494. Netherlands Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 495. Netherlands Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 496. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 497. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 498. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 499. Rest of Europe Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 500. MEA Sleep Disorder Treatment Drugs Sales, by Country K Units (2025-2030)
  • Table 501. MEA Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 502. MEA Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 503. MEA Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 504. MEA Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 505. Middle East Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 506. Middle East Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 507. Middle East Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 508. Middle East Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 509. Africa Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 510. Africa Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 511. Africa Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 512. Africa Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 513. North America Sleep Disorder Treatment Drugs Sales, by Country K Units (2025-2030)
  • Table 514. North America Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 515. North America Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 516. North America Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 517. North America Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 518. United States Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 519. United States Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 520. United States Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 521. United States Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 522. Canada Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 523. Canada Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 524. Canada Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 525. Canada Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 526. Mexico Sleep Disorder Treatment Drugs Sales, by Type K Units (2025-2030)
  • Table 527. Mexico Sleep Disorder Treatment Drugs Sales, by Application K Units (2025-2030)
  • Table 528. Mexico Sleep Disorder Treatment Drugs Sales, by Sleep disorder K Units (2025-2030)
  • Table 529. Mexico Sleep Disorder Treatment Drugs Sales, by Devices K Units (2025-2030)
  • Table 530. Sleep Disorder Treatment Drugs: by Type(USD/Units)
  • Table 531. Research Programs/Design for This Report
  • Table 532. Key Data Information from Secondary Sources
  • Table 533. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Sleep Disorder Treatment Drugs: by Type USD Million (2018-2023)
  • Figure 5. Global Sleep Disorder Treatment Drugs: by Application USD Million (2018-2023)
  • Figure 6. Global Sleep Disorder Treatment Drugs: by Sleep disorder USD Million (2018-2023)
  • Figure 7. Global Sleep Disorder Treatment Drugs: by Devices USD Million (2018-2023)
  • Figure 8. South America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 9. Asia Pacific Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 10. Europe Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 11. MEA Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 12. North America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 13. Global Sleep Disorder Treatment Drugs: by Type K Units (2018-2023)
  • Figure 14. Global Sleep Disorder Treatment Drugs: by Application K Units (2018-2023)
  • Figure 15. Global Sleep Disorder Treatment Drugs: by Sleep disorder K Units (2018-2023)
  • Figure 16. Global Sleep Disorder Treatment Drugs: by Devices K Units (2018-2023)
  • Figure 17. South America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 18. Asia Pacific Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 19. Europe Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 20. MEA Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 21. North America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 22. Global Sleep Disorder Treatment Drugs: by Type USD/Units (2018-2023)
  • Figure 23. Global Sleep Disorder Treatment Drugs share by Players 2023 (%)
  • Figure 24. Global Sleep Disorder Treatment Drugs share by Players (Top 3) 2023(%)
  • Figure 25. Global Sleep Disorder Treatment Drugs share by Players (Top 5) 2023(%)
  • Figure 26. BCG Matrix for key Companies
  • Figure 27. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 28. Pfizer (United States) Revenue: by Geography 2023
  • Figure 29. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 30. Sanofi (France) Revenue: by Geography 2023
  • Figure 31. Merck Sharp & Dohme Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 32. Merck Sharp & Dohme Corporation (United States) Revenue: by Geography 2023
  • Figure 33. GlaxoSmithKline (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. GlaxoSmithKline (United Kingdom) Revenue: by Geography 2023
  • Figure 35. Koninklijke Philips N.V. (Netherlands) Revenue, Net Income and Gross profit
  • Figure 36. Koninklijke Philips N.V. (Netherlands) Revenue: by Geography 2023
  • Figure 37. Takeda Pharmaceutical Company (Japan) Revenue, Net Income and Gross profit
  • Figure 38. Takeda Pharmaceutical Company (Japan) Revenue: by Geography 2023
  • Figure 39. Leva Pharmaceutical Industries (Pakistan) Revenue, Net Income and Gross profit
  • Figure 40. Leva Pharmaceutical Industries (Pakistan) Revenue: by Geography 2023
  • Figure 41. Cardinal Health, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 42. Cardinal Health, Inc. (United States) Revenue: by Geography 2023
  • Figure 43. Global Sleep Disorder Treatment Drugs: by Type USD Million (2025-2030)
  • Figure 44. Global Sleep Disorder Treatment Drugs: by Application USD Million (2025-2030)
  • Figure 45. Global Sleep Disorder Treatment Drugs: by Sleep disorder USD Million (2025-2030)
  • Figure 46. Global Sleep Disorder Treatment Drugs: by Devices USD Million (2025-2030)
  • Figure 47. South America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 48. Asia Pacific Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 49. Europe Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 50. MEA Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 51. North America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 52. Global Sleep Disorder Treatment Drugs: by Type K Units (2025-2030)
  • Figure 53. Global Sleep Disorder Treatment Drugs: by Application K Units (2025-2030)
  • Figure 54. Global Sleep Disorder Treatment Drugs: by Sleep disorder K Units (2025-2030)
  • Figure 55. Global Sleep Disorder Treatment Drugs: by Devices K Units (2025-2030)
  • Figure 56. South America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 57. Asia Pacific Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 58. Europe Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 59. MEA Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 60. North America Sleep Disorder Treatment Drugs Share (%), by Country
  • Figure 61. Global Sleep Disorder Treatment Drugs: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Pfizer (United States)
  • Sanofi (France)
  • Merck Sharp & Dohme Corporation (United States)
  • GlaxoSmithKline (United Kingdom)
  • Koninklijke Philips N.V. (Netherlands)
  • Takeda Pharmaceutical Company (Japan)
  • Leva Pharmaceutical Industries (Pakistan)
  • Cardinal Health, Inc. (United States)
Additional players considered in the study are as follows:
Becton Dickson and Company (United States) , Natus Medicalorporated (United States)
Select User Access Type

Key Highlights of Report


Apr 2024 245 Pages 70 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Sleep Disorder Treatment Drugs Market Quantitative research analysis
Global Sleep Disorder Treatment Drugs Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Sleep Disorder Treatment Drugs Market are by type [Prescription-based Drugs, OTC Drugs and Herbal Drugs], by end use application [Hospitals, Clinics, Research Centers and Others].
The Sleep Disorder Treatment Drugs Market is gaining popularity and expected to see strong valuation by 2030.
  • Increasing Incidence of Depression & Medical Disorder
  • Rising Geriatric Population and Associated Sleep Disorder
  • High Usage of Sleep Apnea Devices and Growing Healthcare Facilities

Know More About Global Sleep Disorder Treatment Drugs Market Report?

Have a Query? Click Here

Other Related Reports

Medication Comprehensive Study by Type (Active Pharmaceutical Ingredients/ Bulk drugs (Branded, Generics), Formulations (Chronic, Acute)), Application (Hospital, Clinic, Other), Sales Channels (Onlin...
$ 3350
Orthopedic Cartilage Repair Comprehensive Study by Type (ACL/PCL, Meniscal Repair, Rotator Cuff, Shoulder Labarum, Hip Arthroscopy, Biceps Tenodesis), Application (Knee, Hip, Shoulder, Others), End U...
$ 3450
Medical Screen Comprehensive Study by Type (Portable, Fixed), Application (Private Clinics, Hospitals, Nursing Homes, Specialty Care Centers), Frame Type (Aluminum, Steel), Number of Panels (One, Two...
$ 3450
Whey Protein Isolate Comprehensive Study by Type (Flavored, Unflavored), Application (Dietary Supplements, Functional Beverages, Functional Food, Others), Distribution Channel (Online, Offline {Hyper...
$ 3650
Ultrasound Gel Warmer Comprehensive Study by Type (Single Bottle Ultrasound Gel Warmer, Two Bottle Ultrasound Gel Warmer, Three Bottle Ultrasound Gel Warmer), Application (Hospital, Clinics, Diagnost...
$ 3650
Wound Retractor Comprehensive Study by Type (Metal Wound Retractor, Plastic Wound Retractor), Application (Hospital, Clinics, Ambulatory Surgical Centres, Others), Distribution Channel (Online Channe...
$ 3800